As of March 2024 AstraZeneca has a market cap of $210.05 Billion. This makes AstraZeneca the world's 54th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $210.05 B | 0.61% |
2023 | $208.77 B | -0.77% |
2022 | $210.38 B | 15.94% |
2021 | $181.46 B | 38.54% |
2020 | $130.98 B | 0.09% |
2019 | $130.87 B | 38.6% |
2018 | $94.42 B | 8.37% |
2017 | $87.12 B | 26.34% |
2016 | $68.96 B | -20.23% |
2015 | $86.45 B | -3.47% |
2014 | $89.56 B | 20.86% |
2013 | $74.10 B | 26.41% |
2012 | $58.62 B | -2.01% |
2011 | $59.82 B | -8.08% |
2010 | $65.08 B | -4.44% |
2009 | $68.10 B | 14.68% |
2008 | $59.39 B | -4.81% |
2007 | $62.38 B | -23.95% |
2006 | $82.03 B | 5.1% |
2005 | $78.05 B | 30.47% |
2004 | $59.82 B | -26.96% |
2003 | $81.90 B | 35.82% |
2002 | $60.30 B | -25.85% |
2001 | $81.33 B |
On Mar 28th, 2024 the market cap of AstraZeneca was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $381.20 B | 81.48% | ๐บ๐ธ USA |
Novartis NVS | $197.71 B | -5.87% | ๐จ๐ญ Switzerland |
Pfizer PFE | $157.13 B | -25.19% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $197.22 B | -6.11% | ๐บ๐ธ USA |
Eli Lilly LLY | $739.65 B | 252.13% | ๐บ๐ธ USA |
Sanofi SNY | $124.08 B | -40.92% | ๐ซ๐ท France |
Biogen BIIB | $31.34 B | -85.08% | ๐บ๐ธ USA |
Merck MRK | $334.18 B | 59.09% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $109.66 B | -47.79% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $87.98 B | -58.11% | ๐ฌ๐ง UK |